Home > Inhibitors & Agonists

Inhibitors & Agonists

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC4526 Rvd2n-3 Dpa Natural potent macrophage uptake enhancer of S. aureus and zymosan A bioparticles
DCC4527 Rwj50271 Inhibitor of LFA-1/ICAM-1 Mediated Cell Adhesion
DCC4528 Rwj-51204 Potent and selective of the benzodiazepine site on GABA(A) receptors
DCC4529 rwj-58259 Selective antagonist of protease activated receptor-1
DCC4530 Rwj-60475 Novel CD45 phosphatase inhibitor
DCC4531 Rx-111 Novel small molecule inhibitor of protein interaction with glycosaminoglycans (SMIGs), exercising broad spectrum anti-inflammatory activity by inhibition of protein binding to the cell surface GAG, heparan sulfate
DCC4532 Rxfp3/4-agonist-1 The first Small Molecule RXFP3/4 Agonist, Increasing Food Intake in Rats Upon Acute Central Administration
DCC4533 Ryl-634 Novel potent broad-spectrum antiviral inhibitor, showing excellent broad-spectrum inhibition activity against various pathogenic viruses, including hepatitis c virus (HCV), dengue virus (DENV), zika virus (ZIKV), Chikungunya virus (CHIKV), enterovirus 71
DCC4534 S(-)-8-hydroxy-dpat Hydrobromide [78095-20-2] Partial 5-HT1A serotonin receptor agonist
DCC4535 S(+)-o-desmethylraclopride Hbr Selective D2 dopamine receptor antagonist; Precursor to radiolabeled S-(-)-raclopride
DCC4536 S007-1558 The most viable GPVI modulator, acting as a potent antithrombotic agent
DCC4537 S05014 Novel highly effective tyrosinase inhibitor with great potential to be utilized in anti-Parkinsonian syndrome
DCC4538 S06-1011 Highly Potent and Selective Butyrylcholinesterase (BChE) Inhibitor for Cognitive Improvement and Neuroprotection
DCC4539 S06-1031 Highly Potent and Selective Butyrylcholinesterase (BChE) Inhibitor for Cognitive Improvement and Neuroprotection
DCC4540 S07662 Inverse agonist of the constitutive androstane receptor (CAR)
DCC4541 S-1033 FP receptor agonist
DCC4542 S-1360 Novel HIV-1 integrase inhibitor
DCC4543 s14161 Novel inhibitor of D-cyclin transactivation via phosphoinositide 3-kinase pathway
DCC4544 S14671 Potent 5-HT1A receptor agonist, also acting as a 5-HT2A and 5-HT2C receptor antagonist
DCC4545 S15535 Potent, orally active, partial 5-HT1A receptor agonist
DCC4546 s17834 Inhibitor of NADPH oxidase, preventing the structural and functional sequelae of diet-induced metabolic heart disease
DCC4547 S-18326 Potent and selective thrombin inhibitor for the treatment of thromboembolic disorders
DCC4548 S18327 Novel, Potential Antipsychotic Displaying Marked Antagonist Properties at α1- and α2-Adrenergic Receptors
DCC4549 S18616 Hydrochloride Selective and highly potent alpha2-adrenoceptor agonist
DCC4550 S1pr4-agonist-5c Novel potent and selective agonist activity for S1PR4
DCC4551 S1r-in-10 Novel selective sigma 1 receptor (S1R) antagonist, exhibiting potent binding affinity for S1R, high selectivity over S2R and 87 other human targets, acceptable in vitro metabolic stability, slowing clearance in liver microsomes, and excellent blood-brain
DCC4552 S23515 Hydrochloride Potent and selective ligand of imidazoline 1 receptor (I1R)
DCC4553 S23757 Potent and selective ligand of imidazoline 1 receptor (I1R)
DCC4554 S27847 Potent activator of the AMP-activated protein kinase (AMPK)
DCC4555 S32797 Potent quinone reductase 2 (QR2) inhibitor

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X
>